Clinical trials

It’s time to sit up and take notice of mitochondria

Clinical trials

Biotech Longeveron files for $30M IPO

Clinical trials

Drusolv targets macular degeneration with statin therapy

Drusolv seeks $2 million to prepare IND application for repurposed statin for treatment of AMD ahead of Phase 2 trials.
Clinical trials

New Buck Institute study is treasure trove for longevity research

Clinical trials

Proving the longevity potential of spermidine

Clinical trials

Senolytic start-up gears up for clinical trials

Clinical trials

Gerostate Alpha: “Our phenotype is lifespan”

Clinical trials

“The major modulators of aging remain to be discovered”

Clinical trials

New Longevity supplement targets cognitive decline

Clinical trials

A year in Longevity: progress perspectives

Clinical trials

A year in Longevity: different perspectives

Clinical trials

A year in Longevity: founders’ perspectives

Clinical trials

A year in Longevity: science perspectives

Clinical trials

Longevity biomarker firm to align CROs, pharma and consumers

Clinical trials

BioAge CEO: “It’s all about the data.”

Clinical trials

BioAge lands $90 million; gears up for clinical trials in 2021

Clinical trials

Defining Alzheimer’s by biomarkers could improve clinical trials

Clinical trials

Targeting inflammaging: the hidden “inflammapath” inside us

Clinical trials

Let’s initiate trials of potential geroprotective therapies

Clinical trials

AgelessRx and funding an IRB-approved rapamycin trial

Clinical trials

COVID-19: Leading clinician calls for focus on the biology of aging

Clinical trials

Big Brother approach to accelerate preclinical studies

Clinical trials

ChromaDex releases results for NR study in C19 patients

Clinical trials

Using small data to target Alzheimer’s

Clinical trials

Combining existing medicines to target aging

Clinical trials

Longevity marketing and the need for clarity

Clinical trials

New immune aging drug brings Longevity and C19 hope

Clinical trials

Longevity trials: time to change the approach?

Clinical trials

Leading academic sees “great promise” in longevity supplements

Clinical trials

AKG study first to show “dramatically compressed” morbidity in mammals

Clinical trials

Healthy aging – it’s still all about diet and exercise. For now

Clinical trials

$2m Longevity boost for rapamycin Alzheimer’s study

Clinical trials